Načítá se...
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
BACKGROUND: Tenofovir (TDF) is considered as the first line therapy for chronic hepatitis B. This study presents the results of TDF monotherapy in patients who failed previous nucleoside analogue treatment. METHODS: The study included 29 patients treated with TDF 245 mg once daily for 18 months afte...
Uloženo v:
| Vydáno v: | Hepatol Int |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer India
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778152/ https://ncbi.nlm.nih.gov/pubmed/26612013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-015-9681-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|